Eiger Biopharmaceuticals


2 Notable Biotech Calls

It has not been a good day for investors this Thursday.  Worries about trade, the situation in Saudi Arabia, plunging oil prices, falling …

Eiger (EIGR) Successfully Licensed Rights to Progeria; Wedbush Boosts Price Target

Many investors hope to win big on biotech stocks as shares can skyrocket when there’s good news. Case in point: Eiger Biopharmaceuticals (NASDAQ:EIGR) …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts